| Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ... The Lancet Neurology 19 (5), 422-433, 2020 | 1056 | 2020 |
| Microglial activation and tau propagate jointly across Braak stages TA Pascoal, AL Benedet, NJ Ashton, MS Kang, J Therriault, M Chamoun, ... Nature medicine 27 (9), 1592-1599, 2021 | 392 | 2021 |
| Mapping neurotransmitter systems to the structural and functional organization of the human neocortex JY Hansen, G Shafiei, RD Markello, K Smart, SML Cox, M Nørgaard, ... Nature neuroscience 25 (11), 1569-1581, 2022 | 385 | 2022 |
| Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain KP Ng, TA Pascoal, S Mathotaarachchi, J Therriault, MS Kang, M Shin, ... Alzheimer's research & therapy 9, 1-9, 2017 | 351 | 2017 |
| SPECT imaging of striatal pre-and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep M Michaud, JP Soucy, A Chabli, G Lavigne, J Montplaisir Journal of neurology 249, 164-170, 2002 | 350 | 2002 |
| Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease X Hadoux, F Hui, JKH Lim, CL Masters, A Pébay, S Chevalier, J Ha, S Loi, ... Nature communications 10 (1), 4227, 2019 | 244 | 2019 |
| Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia Z Ismail, SE Black, R Camicioli, H Chertkow, N Herrmann, R Laforce Jr, ... Alzheimer's & Dementia 16 (8), 1182-1195, 2020 | 218 | 2020 |
| Association of apolipoprotein E ε4 with medial temporal tau independent of amyloid-β J Therriault, AL Benedet, TA Pascoal, S Mathotaarachchi, M Chamoun, ... JAMA neurology 77 (4), 470-479, 2020 | 215 | 2020 |
| 18F-MK-6240 PET for early and late detection of neurofibrillary tangles TA Pascoal, J Therriault, AL Benedet, M Savard, FZ Lussier, M Chamoun, ... Brain 143 (9), 2818-2830, 2020 | 207 | 2020 |
| Abnormal metabolic network activity in REM sleep behavior disorder F Holtbernd, JF Gagnon, RB Postuma, Y Ma, CC Tang, A Feigin, ... Neurology 82 (7), 620-627, 2014 | 193 | 2014 |
| Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single-photon-emission computed tomography F Lobbezoo, JP Soucy, JY Montplaisir, GJ Lavigne Journal of dental research 75 (10), 1804-1810, 1996 | 190 | 1996 |
| Quantification of brain cholinergic denervation in Alzheimer’s disease using PET imaging with [18F]-FEOBV M Aghourian, C Legault-Denis, JP Soucy, P Rosa-Neto, S Gauthier, ... Molecular psychiatry 22 (11), 1531-1538, 2017 | 189 | 2017 |
| Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4) S Gauthier, C Patterson, H Chertkow, M Gordon, N Herrmann, ... Canadian geriatrics journal 15 (4), 120, 2012 | 184 | 2012 |
| Biomarker modeling of Alzheimer’s disease using PET-based Braak staging J Therriault, TA Pascoal, FZ Lussier, C Tissot, M Chamoun, G Bezgin, ... Nature aging 2 (6), 526-535, 2022 | 180 | 2022 |
| Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials F Lobbezoo, JP Soucy, NG Hartman, JY Montplaisir, GJ Lavigne Journal of dental research 76 (9), 1610-1614, 1997 | 166 | 1997 |
| In vivo quantification of neurofibrillary tangles with [18F]MK-6240 TA Pascoal, M Shin, MS Kang, M Chamoun, D Chartrand, ... Alzheimer's research & therapy 10, 1-14, 2018 | 165 | 2018 |
| The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging–guided PET study with 11C-PK11195 in acute subcortical stroke A Thiel, BA Radlinska, C Paquette, M Sidel, JP Soucy, R Schirrmacher, ... Journal of Nuclear Medicine 51 (9), 1404-1412, 2010 | 165 | 2010 |
| Assessing whole brain perfusion changes in patients with REM sleep behavior disorder S Mazza, JP Soucy, P Gravel, M Michaud, R Postuma, ... Neurology 67 (9), 1618-1622, 2006 | 157 | 2006 |
| Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease TA Pascoal, S Mathotaarachchi, S Mohades, AL Benedet, CO Chung, ... Molecular psychiatry 22 (2), 306-311, 2017 | 146 | 2017 |
| Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals FZ Lussier, TA Pascoal, M Chamoun, J Therriault, C Tissot, M Savard, ... Alzheimer's & dementia 16 (1), 192-199, 2020 | 144 | 2020 |
